Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-29 4:30 pm Sale | 13D | Kamada Ltd. KMDA | Brosh Capital Partners L.P. | 2,082,835 4.7% | -356,338 (-14.61%) | View |
| 2019-12-02 5:12 pm Sale | 13D | Kamada Ltd. KMDA | Brosh Capital Partners L.P. | 2,439,173 6% | -655,548 (-21.18%) | View |
| 2018-06-11 5:20 pm Unchanged | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Brosh Capital Partners L.P. | 569,179 5.3% | 0 (Unchanged) | View |
| 2018-04-30 4:24 pm Purchase | 13D | Arcturus Therapeutics Holdings Inc. ARCT | Brosh Capital Partners L.P. | 569,179 5.3% | 6,810 (+1.21%) | View |
| 2018-04-09 5:18 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Brosh Capital Partners L.P. | 562,369 5.3% | 73,754 (+15.09%) | View |